N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide

C162H158F16N24O18 — CID 158042748

IUPACN-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide
SMILESCc1ccc(NC(=O)c2ccnc(C(C)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.Cc1ccc(NC(=O)c2ccnc(C(C)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1ccc2c(c1)N1CCOCC1C(CO)(CO)C2.Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1ccc2c(c1)N1CCOCC1c1cn(C)nc1-2.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O
InChIInChI=1S/C28H24F3N5O2.C28H28F3N3O4.2C27H28F2N4O3.2C26H25F3N4O3/c1-16-3-5-19(33-27(37)18-7-8-32-25(12-18)28(29,30)31)13-21(16)17-4-6-20-23(11-17)36-9-10-38-15-24(36)22-14-35(2)34-26(20)22;1-17-2-5-21(33-26(37)19-6-7-32-24(11-19)28(29,30)31)12-22(17)18-3-4-20-13-27(15-35,16-36)25-14-38-9-8-34(25)23(20)10-18;2*1-16-4-5-19(32-25(34)17-6-7-30-23(11-17)27(3,28)29)12-21(16)18-10-22-24(31-14-18)26(2,35)13-20-15-36-9-8-33(20)22;2*1-15-21(10-19(13-30-15)32-24(34)16-4-3-5-18(8-16)26(27,28)29)17-9-22-23(31-12-17)25(2,35)11-20-14-36-7-6-33(20)22/h3-8,11-14,24H,9-10,15H2,1-2H3,(H,33,37);2-7,10-12,25,35-36H,8-9,13-16H2,1H3,(H,33,37);2*4-7,10-12,14,20,35H,8-9,13,15H2,1-3H3,(H,32,34);2*3-5,8-10,12-13,20,35H,6-7,11,14H2,1-2H3,(H,32,34)
InChIKeyFINXASYZGJWDDK-UHFFFAOYSA-N
MW3033.16 g/mol
LogP28.02
Rot. Bonds22

About N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide

N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide (PubChem CID 158042748) has the molecular formula C162H158F16N24O18 and a molecular weight of 3033.16 g/mol. Its IUPAC name is N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide.

Molecular Properties

Compound NameN-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide
PubChem CID158042748
Molecular FormulaC162H158F16N24O18
Molecular Weight3033.16 g/mol
Exact Mass3031.19
IUPAC NameN-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide
SMILESCc1ccc(NC(=O)c2ccnc(C(C)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.Cc1ccc(NC(=O)c2ccnc(C(C)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1ccc2c(c1)N1CCOCC1C(CO)(CO)C2.Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1ccc2c(c1)N1CCOCC1c1cn(C)nc1-2.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O
InChIInChI=1S/C28H24F3N5O2.C28H28F3N3O4.2C27H28F2N4O3.2C26H25F3N4O3/c1-16-3-5-19(33-27(37)18-7-8-32-25(12-18)28(29,30)31)13-21(16)17-4-6-20-23(11-17)36-9-10-38-15-24(36)22-14-35(2)34-26(20)22;1-17-2-5-21(33-26(37)19-6-7-32-24(11-19)28(29,30)31)12-22(17)18-3-4-20-13-27(15-35,16-36)25-14-38-9-8-34(25)23(20)10-18;2*1-16-4-5-19(32-25(34)17-6-7-30-23(11-17)27(3,28)29)12-21(16)18-10-22-24(31-14-18)26(2,35)13-20-15-36-9-8-33(20)22;2*1-15-21(10-19(13-30-15)32-24(34)16-4-3-5-18(8-16)26(27,28)29)17-9-22-23(31-12-17)25(2,35)11-20-14-36-7-6-33(20)22/h3-8,11-14,24H,9-10,15H2,1-2H3,(H,33,37);2-7,10-12,25,35-36H,8-9,13-16H2,1H3,(H,33,37);2*4-7,10-12,14,20,35H,8-9,13,15H2,1-3H3,(H,32,34);2*3-5,8-10,12-13,20,35H,6-7,11,14H2,1-2H3,(H,32,34)
InChIKeyFINXASYZGJWDDK-UHFFFAOYSA-N
XLogP28.02
TPSA517.52 Ų
H-Bond Donors12
H-Bond Acceptors36
Rotatable Bonds22
Heavy Atoms220
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003033.16
LogP ≤ 528.02
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1036

Analyze N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide?
The IUPAC name of N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide (CID 158042748) is N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide.
What is the SMILES notation for N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide?
The canonical SMILES for N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide is Cc1ccc(NC(=O)c2ccnc(C(C)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.Cc1ccc(NC(=O)c2ccnc(C(C)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1ccc2c(c1)N1CCOCC1C(CO)(CO)C2.Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1ccc2c(c1)N1CCOCC1c1cn(C)nc1-2.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc2c(c1)N1CCOCC1CC2(C)O.
What is the InChIKey of N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide?
The InChIKey is FINXASYZGJWDDK-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H24F3N5O2.C28H28F3N3O4.2C27H28F2N4O3.2C26H25F3N4O3/c1-16-3-5-19(33-27(37)18-7-8-32-25(12-18)28(29,30)31)13-21(16)17-4-6-20-23(11-17)36-9-10-38-15-24(36)22-14-35(2)34-26(20)22;1-17-2-5-21(33-26(37)19-6-7-32-24(11-19)28(29,30)31)12-22(17)18-3-4-20-13-27(15-35,16-36)25-14-38-9-8-34(25)23(20)10-18;2*1-16-4-5-19(32-25(34)17-6-7-30-23(11-17)27(3,28)29)12-21(16)18-10-22-24(31-14-18)26(2,35)13-20-15-36-9-8-33(20)22;2*1-15-21(10-19(13-30-15)32-24(34)16-4-3-5-18(8-16)26(27,28)29)17-9-22-23(31-12-17)25(2,35)11-20-14-36-7-6-33(20)22/h3-8,11-14,24H,9-10,15H2,1-2H3,(H,33,37);2-7,10-12,25,35-36H,8-9,13-16H2,1H3,(H,33,37);2*4-7,10-12,14,20,35H,8-9,13,15H2,1-3H3,(H,32,34);2*3-5,8-10,12-13,20,35H,6-7,11,14H2,1-2H3,(H,32,34).
What are the key properties of N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide?
N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide has a molecular weight of 3033.16 g/mol, XLogP of 28.02, 22 rotatable bonds, 12 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[5,5-bis(hydroxymethyl)-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinolin-9-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;bis(2-(1,1-difluoroethyl)-N-[3-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-4-methylphenyl]pyridine-4-carboxamide);bis(N-[5-(6-hydroxy-6-methyl-2,4,4a,5-tetrahydro-1H-[1,4]oxazino[4,3-a][1,5]naphthyridin-9-yl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide);N-[4-methyl-3-(4-methyl-9-oxa-3,4,12-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2,5,14,16-pentaen-15-yl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide is sourced from PubChem (CID 158042748), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).